APA (7th ed.) Citation

CM, T., TH, C., E, d. J., A, B., RM, Z., J, S., . . . WJ, L. (2022). Retinoic Acid Induces an IFN-Driven Inflammatory Tumour Microenvironment, Sensitizing to Immune Checkpoint Therapy. Frontiers in oncology, 12, 849793. https://doi.org/10.3389/fonc.2022.849793

Chicago Style (17th ed.) Citation

CM, Tilsed, et al. "Retinoic Acid Induces an IFN-Driven Inflammatory Tumour Microenvironment, Sensitizing to Immune Checkpoint Therapy." Frontiers in Oncology 12 (2022): 849793. https://doi.org/10.3389/fonc.2022.849793.

MLA (9th ed.) Citation

CM, Tilsed, et al. "Retinoic Acid Induces an IFN-Driven Inflammatory Tumour Microenvironment, Sensitizing to Immune Checkpoint Therapy." Frontiers in Oncology, vol. 12, 2022, p. 849793, https://doi.org/10.3389/fonc.2022.849793.